Oragenics, Inc.
(NYSE Amex Equities : OGEN)

( )
OGEN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
0.30%294.141.4%$886.90m
AMGNAmgen, Inc.
-0.19%220.701.3%$490.85m
CELGCelgene Corp.
0.03%109.571.3%$444.88m
GILDGilead Sciences, Inc.
-1.13%64.641.0%$396.62m
ILMNIllumina, Inc.
0.55%295.003.5%$302.62m
VRTXVertex Pharmaceuticals, Inc.
0.29%201.901.9%$286.11m
REGNRegeneron Pharmaceuticals, Inc.
0.73%344.282.6%$267.21m
EXASEXACT Sciences Corp.
-3.74%80.5324.0%$194.90m
ALXNAlexion Pharmaceuticals, Inc.
-1.61%109.012.0%$188.88m
SGENSeattle Genetics, Inc.
-0.04%108.306.1%$124.42m
BMRNBioMarin Pharmaceutical, Inc.
-0.75%75.334.3%$106.48m
AAgilent Technologies, Inc.
0.27%76.851.6%$101.75m
SRPTSarepta Therapeutics, Inc.
-1.56%94.7814.6%$90.92m
MRTXMirati Therapeutics, Inc.
-1.53%103.182.3%$88.52m
NBIXNeurocrine Biosciences, Inc.
0.07%110.855.0%$79.43m

Company Profile

Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of lantibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.